นักวิจัย: Yot Teerawattananon, MD, PhD Dr. Yot Teerawattananon has received the ISPOR Best Contributed Podium Presentation Award on “Value of Information: An application in health economic evaluation of renal replacement therapy in Thailand” at ISPOR 2nd Asia-Pacific Conference, which was held in Sh

Researcher: Yot Teerawattananon, MD, PhD The ISPOR International Fellowship Award was established in 2006 to recognize key individuals who would contribute to the development of pharmacoeconomics and outcomes research or the use of outcomes research in health care decision in their own country/regio

On 13 Oct, 2021, our outstanding presenters received big achievements by winning amazing awards at the 9th HTAsiaLink Annual Virtual Conference 2021 which virtually held on 11 – 13  October 2021. The winners are as listed below:Best Oral Presentation HSS 1st WINNER: Chanida EkakkararungrojBest Poste

The HTAsiaLink Annual Conference for this year happened on 4 – 7 September, hosted by the Malaysia Health Technology Assessment Section (MaHTAS) under the Ministry of Health, Malaysia. Researchers from HITAP participated in the conference and presented their research projects thr

On 2 Dec 2022, our outstanding presenters received big achievements by winning amazing awards at the 10th HTAsiaLink Annual Conference 2022 which virtually held on 30 November – 2 December 2022. The winners are as listed below:Best Oral PresentationsTrack: Economic EvaluationSecond Prize: Chittawan

The purpose of this study is to compare the cost-utility of each treatment option available today in order to determine the most cost-effective treatment compared with standard treatment in the social perspective. Research methodology is an economic evaluation by using the markov model to compare the cost and utility of treatment options of new pat

Thailand has promoted the use of herbal medicine for many years, but the value of herbal medicine in public health facilities does not meet the established target. The survey of health practitioners towards herbal medicine and the policy in promotion of the use of herbal medicine in health practitioners gives us information reinforcing and resistan

The objective of this study is to promote the rational drug use of Thailand. E List, clause 2 for specific patients is added in the National List of Essential Medicines, 2551 B.E. Ten medicines, which require knowledge, specialization in disease or advanced technology, are included in the list. However, it is likely that the prescription of these m

This study aims to explore effectiveness of home visit on clinical, economic, and humanistic outcomes employing systematic review. Home visits for all diseases and within all patient groups are included, provided that inclusion criteria are met. Results are expected to be useful for (1) developing guidelines for home visit for health professionals,

Background: Osteoporosis, a reduction in bone strength, is one of the most significant factors contributing to fractures, particularly in postmenopausal women. It affects not only patients’ life expectancy and quality of life, but also household expenditure on healthcare costs. Various screening methods to identify the risk of developing osteopo